Menarini Group and Insilico Medicine Ink Second Global AI-Driven Oncology Deal for High Unmet Medical Needs
Menarini Group and Insilico Medicine Forge Second AI-Driven Oncology Partnership FLORENCE,Italy,and CAMBRIDGE,Mass.— in a groundbreaking move, the menarini Group, a global leader in pharmaceuticals and diagnostics, and Insilico Medicine, a trailblazer in AI-driven drug discovery, have announced their second exclusive licensing agreement. This collaboration focuses on a preclinical small molecule targeting high unmet needs in … Read more